Learning Objectives:

1.  Highlight novel insights and therapeutic approaches for idopathic, multicentric Castleman disease and other cytokine storm disorders.

2.  Discuss the potential for drug repurposing to address conditions without available treatment options including -7,000 rare diseases.


Session date: 
06/29/2022 - 7:00am to 8:00am CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
David Fajgenbaum MD, MBA, MSC